+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07900581

Genomic and Transcriptomic Analysis of Prognostic Biomarkers in Non-Small Cell Lung Cancer Patients Supported by the Hellenic Cooperative Oncology Group

Led by Hellenic Cooperative Oncology Group · Updated on 2026-10-28

300

Participants Needed

20

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a non-interventional translational research study to examine the genetic and transcriptomic features of patients with non-small cell lung cancer NSCLC. The study focuses on analyzing tumor and blood samples to uncover genomic changes, mutational patterns, and gene expression profiles linked to patient outcomes and responses to immunotherapy. Approximately 300 patients with confirmed NSCLC, including both early-stage and metastatic cases, will participate. Participants will provide formalin-fixed paraffin-embedded FFPE tumor tissue and blood samples. Some may also provide fresh frozen tumor samples. The study includes whole-exome sequencing and RNA sequencing to identify clinically relevant genetic alterations, tumor mutational burden, and immune-related gene signatures. A smaller subgroup of about 20 patients with unresectable stage III NSCLC will be followed in a pilot sub-study to analyze circulating tumor DNA ctDNA over time during and after chemoradiation and durvalumab maintenance therapy. Throughout the study, researchers will collect tumor tissue, blood, and plasma samples at various timepoints. They will analyze these samples for molecular markers and track changes in ctDNA in the sub-study group. The main outcomes include the prevalence of genomic alterations, tumor mutational burden, and immune subtypes at baseline. The study aims to enhance understanding of NSCLC biology and support the discovery of biomarkers for prognosis and immunotherapy response. The study is expected to continue until the end of 2026.

CONDITIONS

Brief Title

Analysis of Whole Exome and Transcriptome Sequencing to Identify Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC)

Research Team

E

Elefteria Tsolaki

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here